Silver Spring, MD, United States of America

Mario A Anzano

This inventor holds 1 USPTO granted patent. Top assignee: The United States of America as Represented by the Department of Health. Active years: 1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mario A Anzano. Retrieved from https://idiyas.com/inventor/mario-a-anzano

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Mario A. Anzano

Introduction

Mario A. Anzano is a notable inventor based in Silver Spring, MD (US). He has made significant contributions to the field of cancer treatment through his innovative research and patents. His work focuses on the use of 9-cis-retinoic acid and its derivatives in preventing and treating various types of cancer, particularly breast cancer.

Latest Patents

Mario A. Anzano holds 1 patent related to his groundbreaking work. His patent, titled "Uses of 9-cis-retinoic acids and derivatives thereof alone or in combination," outlines methods and compositions for preventing or treating cancer. This invention specifically emphasizes the application of 9-cis-retinoic acid or its derivatives in combating breast cancer. Additionally, it discusses the formulation of compositions that include 9-cis-retinoic acid alongside at least one other antineoplastic agent for enhanced efficacy in cancer treatment.

Career Highlights

Anzano's career is marked by his association with the United States of America as represented by the Department of Health. His dedication to cancer research has positioned him as a key figure in the development of innovative therapeutic strategies. His work has the potential to impact the lives of many individuals affected by cancer.

Collaborations

Mario A. Anzano has collaborated with notable professionals in his field, including Michael B. Sporn. These collaborations have further enriched his research and contributed to the advancement of cancer treatment methodologies.

Conclusion

In summary, Mario A. Anzano's contributions to cancer research through his patent on 9-cis-retinoic acid highlight his commitment to improving treatment options for patients. His innovative work continues to pave the way for future advancements in the fight against cancer.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…